Related Experiment Video
Updated: Mar 13, 2026
05:18
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
1.7K
Colonic acetate in obesity: location matters!
Laure B Bindels1, Isabelle Leclercq2
1Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Avenue E. Mounier, 73, B1.73.11, 1200 Brussels, Belgium.
Clinical Science (London, England : 1979)
|October 13, 2016
Summary
This study investigated acetate, a gut microbial byproduct, in overweight and obese individuals. Acetate infusion may influence host metabolism and immunity, offering potential therapeutic avenues.
Area of Science:
- Microbiology
- Immunology
- Metabolism
Background:
- Gut microbiota plays a critical role in regulating host immunity.
- Microbiota dysbiosis is linked to inflammatory, immune, and psychiatric conditions.
- Human translational research is essential for clinical applications.
Purpose of the Study:
- To evaluate the effects of colonic acetate infusion.
- To investigate acetate's role as a metabolic modulator.
- To explore potential therapeutic applications in human subjects.
Main Methods:
- Colonic infusion of acetate.
- Study cohort: overweight and obese normoglycaemic subjects.
- Analysis of host-microbiota interactions.
Main Results:
- Acetate infusion modulated host metabolism.
- Observed effects on immune markers.
- Data provides insights into short-chain fatty acid functions.
Conclusions:
- Acetate, a microbial metabolite, influences host physiology.
- Further research warranted for diagnostic and therapeutic use.
- Highlights the importance of gut microbiota in metabolic health.
Related Concept Videos
01:21Drugs for Treatment of Constipation-Predominant IBS
1.1K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.1K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
262
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
262
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
343
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
343
01:29Drugs for Treatment of Ulcerative Colitis in IBD
589
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
589
01:21Drug Dosing: Obese Patients
325
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
325
01:17Chronic Bowel Disorders: Introduction
871
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
871